CR250117C190000
- 0.31
- 0.000.00%
Crane Newsroom
Brian Crane, CEO of Intero, a Berkshire Hathaway Affiliate, Named Among the 2025 Swanepoel Power 200 List
China Resources Double-Crane Pharmaceutical Gets Listing Approval for Heparin Sodium API
Are Robust Financials Driving The Recent Rally In Crane NXT, Co.'s (NYSE:CXT) Stock?
Crane NXT to Participate in the CJS Securities 25th Annual New Ideas for the New Year Conference
Press Release: Crane Company Announces Date for Fourth Quarter 2024 Earnings Release and Teleconference
Express News | Crane Company Announces Date for Fourth Quarter 2024 Earnings Release and Teleconference
Nouvelair Airlines Saves 25% on Check-in Costs With Hitit and Regula Partnership
Q3 Earnings Highs And Lows: Crane (NYSE:CR) Vs The Rest Of The General Industrial Machinery Stocks
Crane Is Maintained at Neutral by UBS
Crane Analyst Ratings
Express News | Crane Co : UBS Raises Target Price to $157 From $152
A Piece Of The Puzzle Missing From China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Share Price
Press Release: Crane Company Announces Close of Engineered Materials Divestiture
Express News | Crane Company Announces Close of Engineered Materials Divestiture
U.S. Companies With Potential Pension Risk Transfer Restructuring Opportunities
China Resources Double-Crane Pharmaceutical Passes Generic Drug Evaluation for Pentazocine Injection
At US$154, Is Crane Company (NYSE:CR) Worth Looking At Closely?
China Resources Double-Crane Pharmaceutical Plans Up to 500-Million-Yuan Investment in Financial Products
Zhuzhou Tianqiao Crane Co., Ltd.'s (SZSE:002523) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
CR Double-Crane Pharma Gets Europe's Suitability Certificate for Dienogest